Provided herein are methods for treating or preventing triple negative breast cancer or hormone receptor positive breast cancer, comprising administering an effective amount of a TOR kinase inhibitor to a patient having triple negative breast cancer or hormone receptor positive breast cancer.
申请公布号
CA2867348(A1)
申请公布日期
2013.09.19
申请号
CA20132867348
申请日期
2013.03.14
申请人
SIGNAL PHARMACEUTICALS, LLC
发明人
XU, SHUICHAN;HEGE, KRISTEN MAE;RAYMON, HEATHER;NARLA, RAMA K.